SCHEMBL6162706

SCHEMBL6162706

Fc1ccc(OCCCCN2CCN(c3ccc(Oc4ccccc4)cc3)CC2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.79
DRD2 P14416 7/20 0.79
HTR2A P28223 7/20 0.79
DRD3 P35462 7/20 0.79
HRH1 P35367 6/20 0.79
TMEM97 Q5BJF2 4/20 0.79
SIGMAR1 Q99720 4/20 0.79
SLC6A2 P23975 2/20 0.72
SLC6A4 P31645 2/20 0.72
HRH3 Q9Y5N1 4/20 0.68
HRH2 P25021 2/20 0.68
DRD1 P21728 3/20 0.67
DRD5 P21918 2/20 0.67
ALDH1A1 P00352 2/20 0.61
USP2 O75604 1/20 0.61
HPGD P15428 1/20 0.61
LMNA P02545 3/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
MAPT P10636 1/20 0.61
NLRP1 Q9C000 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167404 0.85 HTR1A (0.70) HTR1ADRD2HTR2ADRD3HRH1
SCHEMBL6162714 0.81 HTR1A (0.70) HTR1ADRD2HTR2ADRD3HRH1
SCHEMBL6161874 0.81 HRH3 (0.69) HTR1ADRD2HTR2ADRD3HRH1
SCHEMBL4348291 0.80 SLC6A2 (0.68) HTR1ADRD2HTR2ADRD3HRH1
SCHEMBL8011318 0.79 DRD2 (0.69) HTR1ADRD2HTR2ADRD3HRH1
SCHEMBL491542 0.78 HRH3 (0.85) HRH1HRH3LMNAMEN1HTT
SCHEMBL1728918 0.78 USP2 (0.78) HTR1ADRD2HTR2ADRD3HRH1
SCHEMBL11277312 0.77 SLC6A2 (0.68) HTR1ADRD2HTR2ADRD3HRH1
SCHEMBL10835875 0.77 DRD2 (0.70) HTR1ADRD2HTR2ADRD3HRH1
SCHEMBL7397911 0.77 HRH3 (0.88) HRH1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0755923-B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-05-04 EP disclosed
US-6469010-B1 COMPOSITION ALSO FOR ALLEVIATION OR TREATMENT OF SYMPTOMS DERIVED FROM SEIZURES, EPILEPSY AND MIGRAINE HEADACHES, AND SUPPRESSION OF CALCIUM ION OVERLOAD SUNTORY LIMITED (JP) 2002-10-22 US disclosed
US-6048876-A ANTICONVULSANTS; ANTIEPILEPIC AGENT SUNTORY LIMITED (JP) 2000-04-11 US disclosed
EP-0755923-A1 AMELIORANT OR REMEDY FOR SYMPTOMS CAUSED BY ISCHEMIC DISEASES AND COMPOUNDS USEFUL THEREFOR SUNTORY LIMITED (JP) 1997-01-29 EP disclosed